Governance of Diabetes Management in Non-specialistic Hospital Settings
調査の概要
詳細な説明
The project aims at defining a model of care for hospitalized diabetic patients in non-specialist settings based on the national and international recommendations. This is a cluster randomized study to evaluate the efficacy of a structured education training program for physicians and nurses in improving an ad hoc composite performance score of diabetes management and some clinical outcomes. The study will be carried out in 6 hospitals of the Emilia-Romagna region in Italy and it will involve 3 different wards (internal medicine, intensive care unit, surgery). For each hospital one intervention and two controls wards will be randomly identified.
At baseline the clinical management of patients with stress hyperglycemia/diabetes will be assessed in all participating wards over a 3-month period. Then, a structured educational program regarding the management of stress hyperglycemia/diabetes in the inpatient setting will be carried out only in the intervention wards. This program will last 2 months. Health care professionals also will be trained in the regular use of appropriate management tools (hyperglycemia dedicated standard operation procedures, audits, etc.).
Three months after the end of the educational program, the 3-month assessment of clinical management of patients with stress hyperglycemia/diabetes will be repeated in all participating wards.
The assessment of clinical management of stress hyperglycemia/diabetes will be based on a set of clinical performance indicators concerning 5 major domains (admission assessment, glucose monitoring, medical therapy, management of consults, management of discharge). These indicators will be used to define a composite performance score of appropriateness and efficacy. The highest score (1) will be assigned when the indicator is monitored, the lowest (0) when the indicator will be not detected, according to the scoring method previously reported by Rossi et al. Therefore, the score of each domain will range between 0 and the number of indicators used to assess appropriateness and efficacy of that domain.
Domain 1 - Initial assessment: score 0-5
- records of admission glycemia
- records of fasting plasma glucose
- records of HbA1c
- appropriate diagnosis of stress hyperglycemia/diabetes mellitus according to ADA
- records of history of presence/absence of pharmacological diabetes therapy
Domain 2 - Glucose monitoring: score 0-4
- appropriate glucose monitoring: at least 80% of three daily preprandial glycemia or, in critically ill patients, monitoring according to the specific algorithm used in the ward
- presence and use of specific forms for glucose records
- presence of ward standing orders to recognize and correct hypoglycemia
- presence of ward standing orders to monitor and manage glucose in critically ill patients (Critically ill patients are defined as patients who require intensive care for acute critical illnesses, such as myocardial infarction, stroke, septic shock or severe respiratory failure, requiring intensive or semi-intensive therapy and, as a rule, not taking food orally during the first 24-72 hours)
Domain 3 - Medical therapy: score 0-2
- records of time and dose of insulin therapy
- interruption of Metformin therapy when indicated (correct indications to discontinuation of Metformin therapy were: any critical illness, acute renal, cardiac and/or respiratory failure, surgery or iodinated contrast agents administration.)
Domain 4 - Consults: score 0-2
- request and records of diabetes specialist consult
- request and records of nursing consult
Domain 5 - Management of discharge: score 0-3
- planning of diabetes follow-up visit after hospitalization
- patient education for home blood glucose self-monitoring
- patient education for all other aspects of diabetes management
The sum of the scores of each domain from 1 to 5 is the composite performance score.
The following clinical outcomes will be recorded both at baseline and 3 months after the end of the educational program in all participating wards.:
- all hypoglycemic events (blood glucose ≤ 70 mg/dl)
- severe hypoglycemic events (blood glucose ≤ 40 mg/dl with or without clouding of consciousness)
- difference between plasma glycemia at admission and mean plasma glucose during the last-48-hours before discharge
- achievement of glycemic goals: 4 consecutive blood glucose levels ≤ 130 mg/dl (preprandial) or ≤ 180 mg/dl (postprandial), or 4 consecutive blood glucose levels between 140 and 180 mg/dl in critically ill patients
- survival
- discharge condition: a score of 0 will be assigned in case of death or transfer to a higher intensity ward and score 1 in all other cases, i.e. home discharge or transferral to a lower intensity ward.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
-
Bologna、イタリア
- AUSL Ospedale Maggiore
-
Ferrara、イタリア、44121
- Azienda Ospedaliero-Universitaria
-
Modena、イタリア
- AUSL Carpi
-
Parma、イタリア、43126
- Azienda Ospedaliero-Universitaria Parma
-
Piacenza、イタリア、29121
- AUSL Piacenza
-
Reggio Emilia、イタリア、42027
- AUSL Montecchio
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- patients with type 2 or type 1 diabetes or stress hyperglycemia
Exclusion Criteria:
- age <18,
- patients hospitalized for diabetic complications: ketoacidosis, hyperosmolar syndrome, hypoglycemic coma, pregnant diabetics or gestational diabetes
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:支持療法
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:educational training
|
implementation of a structured educational program for physicians and nurses
|
|
介入なし:no educational training
no educational training wards
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Composite performance score computed as the sum of the performance scores of all 5 domains of appropriateness and efficacy in both the intervention and the control wards
時間枠:11 months
|
Efficacy of educational training will be evaluated as absolute change of the performance scores after the intervention compared to baseline in the two groups
|
11 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
hypoglycemic events in the intervention and control wards
時間枠:11 months
|
rate difference of hypoglycemia events (blood glucose ≤ 70 mg/dl) in the intervention and control wards
|
11 months
|
|
severe hypoglycemic events in the intervention and control wards
時間枠:11 months
|
rate difference of severe hypoglycemia events (blood glucose ≤ 40 mg/dL with or without clouding of consciousness) in the intervention and control wards
|
11 months
|
|
difference between plasma glycemia at admission and mean plasma glucose during the last-48-hours before discharge
時間枠:11 months
|
difference between plasma glycemia at admission and mean plasma glucose during the last-48-hours before discharge
|
11 months
|
|
achievement of glycemic goals in the intervention and control wards
時間枠:11 months
|
number of patients that achieve glycemic goals: 4 consecutive blood glucose levels ≤ 130 mg/dl (preprandial) or ≤ 180 mg/dl (postprandial), or 4 consecutive blood glucose levels between 140 and 180 mg/dl in critically ill patients
|
11 months
|
|
survival rate during hospitalization in the intervention and control wards
時間枠:11 months
|
survival rate during hospitalization (score 1 for survival, score 0 for death)
|
11 months
|
|
discharge condition in the intervention and control wards
時間枠:11 months
|
a score of 0 will be assigned in case of death or transfer to a higher intensity ward and score 1 in all other cases, i.e. home discharge or transferral to a lower intensity ward.
|
11 months
|
協力者と研究者
捜査官
- 主任研究者:Ivana Zavaroni, MD、Azienda Ospedaliero-Universitaria Parma
出版物と役立つリンク
一般刊行物
- Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 Feb 2;354(5):449-61. doi: 10.1056/NEJMoa052521.
- Cook CB, Castro JC, Schmidt RE, Gauthier SM, Whitaker MD, Roust LR, Argueta R, Hull BP, Zimmerman RS. Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007 Jul;2(4):203-11. doi: 10.1002/jhm.188.
- American Diabetes Association. Standards of medical care in diabetes--2008. Diabetes Care. 2008 Jan;31 Suppl 1:S12-54. doi: 10.2337/dc08-S012. No abstract available.
- Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D, Di Blasi P, Bader G, Pellegrini F, Valentini U, Vespasiani G, Nicolucci A; AMD-QUASAR Study Group. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care. 2011 Feb;34(2):347-52. doi: 10.2337/dc10-1709.
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- AOParma
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。